Osteopontin promotes infarct repair

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Cardiac Pathophysiology

Background:

• Macrophages play a crucial role in myocardial repair following injury.
• Understanding the specific mechanisms by which macrophages promote healing is essential for developing new therapeutic strategies for infarct repair.

Purpose of the Study:

• To investigate the underlying mechanisms of macrophage-mediated myocardial repair.
• To determine the role of osteopontin (OPN) in cardiac healing and its potential as a therapeutic agent.

Main Methods:

• Cytokine array analysis of neonatal cardiac macrophages.
• In vitro studies using recombinant OPN on cardiac cells (cardiomyocytes, endothelial cells, cardiac mesenchymal stromal cells).
• In vivo studies in neonatal and adult mice models of myocardial infarction (MI), including OPN-deficient models and OPN injection therapy.

Main Results:

• Neonatal cardiac macrophages secrete high levels of OPN.
• Recombinant OPN promotes cardiomyocyte cell-cycle re-entry, migration, and cardiac cell outgrowth by activating the CD44 receptor and YAP1 pathway.
• OPN enhances proliferation and migration of non-cardiomyocyte cardiac cells.
• OPN deficiency impairs myocardial healing in neonatal hearts.
• In adult mice, OPN injection improves cardiac function, scar formation, and reduces adverse left ventricular (LV) remodeling post-MI.

Conclusions:

• Osteopontin (OPN) is a key secreted factor from macrophages that drives myocardial repair.
• Recombinant OPN can induce cardiomyocyte cell-cycle re-entry and stimulate various cardiac cells, offering a promising cell-free therapeutic approach for optimizing infarct repair and cardiac function post-MI.